OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuro-Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	68
A practical guide to neuro-oncology fellowship	58
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	54
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	53
Prognostic factors among patients with brain metastases from cancer of unknown primary site	47
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	42
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	42
Factors influencing timely diagnosis in neurolymphomatosis	41
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	39
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	35
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	35
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	34
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	33
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	32
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	32
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	32
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	31
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	31
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale	31
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	29
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	29
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	28
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience	28
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	27
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma	27

Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	26
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	26